Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using machine learning to analyze video recordings of individuals performing simple ...

disease-modifying therapies do not work as well for progressive MS as they do for relapsing forms of MS. That’s why treatment for the final stages of MS focuses on managing individual symptoms.

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

Tavapadon, a drug being tested to treat early Parkinson's disease, has shown great ... purchase of Cerevel Therapeutics last year. In other late-stage trials, tavapadon showed improvement of ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using machine learning to analyze video recordings of individuals performing simple ...